ISRG
INTUITIVE SURGICAL INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$393.33
+2.55%Sep 18, 2026, 12:45 UTC
Intuitive launched its next-generation da Vinci 5 robotic surgical system in India, positioning it in the premium and core market segments while continuing to sell its fourth-generation systems.
Source:Sep 16, 2026, 16:41 UTC
Intuitive Surgical received a CE mark from the European Union to expand its da Vinci SP surgical system into transvaginal gynecologic procedures in Europe.
Source:Sep 15, 2026, 16:10 UTC
Intuitive Surgical released a meta-analysis of its da Vinci surgical system covering 14 million procedures across 13 common conditions, reporting better perioperative outcomes versus laparoscopic and open surgery.
Source:Sep 14, 2026, 21:50 UTC
Intuitive Surgical shares rose 2.38% to close at $377.94, outperforming a 0.48% decline in the S&P 500.
Sep 14, 2026, 15:30 UTC
UK St. Claire is seeking to acquire a Da Vinci surgical robot to perform cancer surgery.
Source:Sep 11, 2026, 23:45 UTC
Intuitive Surgical EVP and Chief Manufacturing and Supply Chain Officer Mark Brosius sold 48 shares of the company's common stock for a total of $17,140 across two transactions on September 10 and 11, 2026, under a pre-arranged Rule 10b5-1 trading plan.
Source:Sep 11, 2026, 05:32 UTC
China's National Healthcare Security Administration held an expert symposium on surgical robots in Beijing on September 11, 2026, with representatives from seven domestic and foreign surgical robot makers and five hospitals.
Source:Aug 19, 2026, 17:41 UTC
Intuitive Surgical is expanding its manufacturing footprint in Asia Pacific by building a new plant in Penang, Malaysia, to increase capacity and support rising demand for robotic-assisted surgery.
Source:Aug 12, 2026, 04:15 UTC
Vietnamese doctors at Tam Anh General Hospital performed the country's first robotic cancer surgery using two US Da Vinci Xi surgical robots in a dual-console setup.
Source:Jul 22, 2026, 11:00 UTC
CONMED Corporation announced that its AirSeal Robotic Solution has received an expanded FDA-cleared indication for use with Intuitive's 8 mm hex cannulas on the da Vinci 5 platform.
Source:Jul 16, 2026, 20:05 UTC
Intuitive announced its financial results for the second quarter ended June 30, 2026.
Jun 10, 2026, 06:22 UTC
Cellares raised $277 million in a Series D financing round, with ARK Invest contributing $20 million.
Source: